Matched-pair comparisons of stereotactic body radiotherapy (SBRT) versus surgery for the treatment of early stage non-small cell lung cancer: A systematic review and meta-analysis
Abstract Purpose A population-based matched-pair comparison was performed to compare the efficacy of stereotactic body radiotherapy (SBRT) versus surgery for early-stage non-small cell lung cancer (NSCLC). Methods All the eligible studies were searched by PubMed, Medline, Embase, and the Cochrane Li...
Gespeichert in:
| Veröffentlicht in: | Radiotherapy and oncology 2014-08, Vol.112 (2), p.250-255 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 255 |
|---|---|
| container_issue | 2 |
| container_start_page | 250 |
| container_title | Radiotherapy and oncology |
| container_volume | 112 |
| creator | Zhang, Binglan Zhu, Fuping Ma, Xuelei Tian, Ye Cao, Dan Luo, Songe Xuan, Yu Liu, Lei Wei, Yuquan |
| description | Abstract Purpose A population-based matched-pair comparison was performed to compare the efficacy of stereotactic body radiotherapy (SBRT) versus surgery for early-stage non-small cell lung cancer (NSCLC). Methods All the eligible studies were searched by PubMed, Medline, Embase, and the Cochrane Library. The meta-analysis was performed to compare odds ratios (OR) for overall survival (OS), cancer-specific survival (CSS), disease-free survival (DFS), local control (LC), and distant control (DC). Results Six studies containing 864 matched patients were included in the meta-analysis. The surgery was associated with a better long-term OS in patients with early-stage NSCLC. The pooled OR and 95% confidence interval (CI) for 1-year, 3-year OS were 1.31 [0.90, 1.91] and 1.82 [1.38, 2.40], respectively. However, the difference in 1-year and 3-year CSS, DFS, LC and DC was not significant. Conclusions This systematic review found a superior 3-year OS after surgery compared with SBRT, which supports the need to compare both treatments in large prospective, randomized, controlled clinical trials. |
| doi_str_mv | 10.1016/j.radonc.2014.08.031 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1629960788</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0167814014003612</els_id><sourcerecordid>1629960788</sourcerecordid><originalsourceid>FETCH-LOGICAL-c529t-bb14c4ae59d39d5e135b29e6b8eee5f4f12974d2576593a931becb1a74bb683c3</originalsourceid><addsrcrecordid>eNqFkstu1TAQhiMEoqeFN0DIy7LIwZdcWSCVqlykIiRa1tbEmZz6kNgHj1OU5-IFcXQKCzZIlr355v8980-WvRB8K7ioXu-3AXrvzFZyUWx5s-VKPMo2oqnbnDdN_TjbJKzOG1Hwk-yUaM85l1zVT7MTWUpV1aLaZL8-QzR32OcHsIEZPx0gWPKOmB8YRQzoI5hoDet8v7BkaX28wwCHhZ3fvPt6-4rdY6CZGM1hh2Fhgw8sESwGhDihi6sSQhiXpAc7ZM67nCYYR2YwXePsdsyAMxjesAtGS3KdYHUMeG_xJwPXswkj5OBgXMjSs-zJACPh84f3LPv2_ur28mN-_eXDp8uL69yUso1514nCFIBl26u2L1GospMtVl2DiOVQDEK2ddHLsq7KVkGrRIemE1AXXVc1yqiz7Pyoewj-x4wU9WRp_TM49DNpUcm2rXjdNAktjqgJnijgoA_BThAWLbhe49J7fYxLr3Fp3ugUVyp7-eAwdxP2f4v-5JOAt0cAU59pGkGTsZhm1duAJure2_85_CtgRuusgfE7Lkh7P4c01dSLJqm5vllXZt2YdLiqhFS_AWZTwQ4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1629960788</pqid></control><display><type>article</type><title>Matched-pair comparisons of stereotactic body radiotherapy (SBRT) versus surgery for the treatment of early stage non-small cell lung cancer: A systematic review and meta-analysis</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Zhang, Binglan ; Zhu, Fuping ; Ma, Xuelei ; Tian, Ye ; Cao, Dan ; Luo, Songe ; Xuan, Yu ; Liu, Lei ; Wei, Yuquan</creator><creatorcontrib>Zhang, Binglan ; Zhu, Fuping ; Ma, Xuelei ; Tian, Ye ; Cao, Dan ; Luo, Songe ; Xuan, Yu ; Liu, Lei ; Wei, Yuquan</creatorcontrib><description>Abstract Purpose A population-based matched-pair comparison was performed to compare the efficacy of stereotactic body radiotherapy (SBRT) versus surgery for early-stage non-small cell lung cancer (NSCLC). Methods All the eligible studies were searched by PubMed, Medline, Embase, and the Cochrane Library. The meta-analysis was performed to compare odds ratios (OR) for overall survival (OS), cancer-specific survival (CSS), disease-free survival (DFS), local control (LC), and distant control (DC). Results Six studies containing 864 matched patients were included in the meta-analysis. The surgery was associated with a better long-term OS in patients with early-stage NSCLC. The pooled OR and 95% confidence interval (CI) for 1-year, 3-year OS were 1.31 [0.90, 1.91] and 1.82 [1.38, 2.40], respectively. However, the difference in 1-year and 3-year CSS, DFS, LC and DC was not significant. Conclusions This systematic review found a superior 3-year OS after surgery compared with SBRT, which supports the need to compare both treatments in large prospective, randomized, controlled clinical trials.</description><identifier>ISSN: 0167-8140</identifier><identifier>EISSN: 1879-0887</identifier><identifier>DOI: 10.1016/j.radonc.2014.08.031</identifier><identifier>PMID: 25236716</identifier><language>eng</language><publisher>Ireland: Elsevier Ireland Ltd</publisher><subject>Carcinoma, Non-Small-Cell Lung - pathology ; Carcinoma, Non-Small-Cell Lung - surgery ; Disease-Free Survival ; Hematology, Oncology and Palliative Medicine ; Humans ; Lung cancer ; Lung Neoplasms - pathology ; Lung Neoplasms - surgery ; Matched-Pair Analysis ; Meta-analysis ; Neoplasm Staging ; Prospective Studies ; Radiosurgery - methods ; Stereotactic body radiotherapy ; Surgery</subject><ispartof>Radiotherapy and oncology, 2014-08, Vol.112 (2), p.250-255</ispartof><rights>Elsevier Ireland Ltd</rights><rights>2014 Elsevier Ireland Ltd</rights><rights>Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c529t-bb14c4ae59d39d5e135b29e6b8eee5f4f12974d2576593a931becb1a74bb683c3</citedby><cites>FETCH-LOGICAL-c529t-bb14c4ae59d39d5e135b29e6b8eee5f4f12974d2576593a931becb1a74bb683c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.radonc.2014.08.031$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25236716$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhang, Binglan</creatorcontrib><creatorcontrib>Zhu, Fuping</creatorcontrib><creatorcontrib>Ma, Xuelei</creatorcontrib><creatorcontrib>Tian, Ye</creatorcontrib><creatorcontrib>Cao, Dan</creatorcontrib><creatorcontrib>Luo, Songe</creatorcontrib><creatorcontrib>Xuan, Yu</creatorcontrib><creatorcontrib>Liu, Lei</creatorcontrib><creatorcontrib>Wei, Yuquan</creatorcontrib><title>Matched-pair comparisons of stereotactic body radiotherapy (SBRT) versus surgery for the treatment of early stage non-small cell lung cancer: A systematic review and meta-analysis</title><title>Radiotherapy and oncology</title><addtitle>Radiother Oncol</addtitle><description>Abstract Purpose A population-based matched-pair comparison was performed to compare the efficacy of stereotactic body radiotherapy (SBRT) versus surgery for early-stage non-small cell lung cancer (NSCLC). Methods All the eligible studies were searched by PubMed, Medline, Embase, and the Cochrane Library. The meta-analysis was performed to compare odds ratios (OR) for overall survival (OS), cancer-specific survival (CSS), disease-free survival (DFS), local control (LC), and distant control (DC). Results Six studies containing 864 matched patients were included in the meta-analysis. The surgery was associated with a better long-term OS in patients with early-stage NSCLC. The pooled OR and 95% confidence interval (CI) for 1-year, 3-year OS were 1.31 [0.90, 1.91] and 1.82 [1.38, 2.40], respectively. However, the difference in 1-year and 3-year CSS, DFS, LC and DC was not significant. Conclusions This systematic review found a superior 3-year OS after surgery compared with SBRT, which supports the need to compare both treatments in large prospective, randomized, controlled clinical trials.</description><subject>Carcinoma, Non-Small-Cell Lung - pathology</subject><subject>Carcinoma, Non-Small-Cell Lung - surgery</subject><subject>Disease-Free Survival</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Lung cancer</subject><subject>Lung Neoplasms - pathology</subject><subject>Lung Neoplasms - surgery</subject><subject>Matched-Pair Analysis</subject><subject>Meta-analysis</subject><subject>Neoplasm Staging</subject><subject>Prospective Studies</subject><subject>Radiosurgery - methods</subject><subject>Stereotactic body radiotherapy</subject><subject>Surgery</subject><issn>0167-8140</issn><issn>1879-0887</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkstu1TAQhiMEoqeFN0DIy7LIwZdcWSCVqlykIiRa1tbEmZz6kNgHj1OU5-IFcXQKCzZIlr355v8980-WvRB8K7ioXu-3AXrvzFZyUWx5s-VKPMo2oqnbnDdN_TjbJKzOG1Hwk-yUaM85l1zVT7MTWUpV1aLaZL8-QzR32OcHsIEZPx0gWPKOmB8YRQzoI5hoDet8v7BkaX28wwCHhZ3fvPt6-4rdY6CZGM1hh2Fhgw8sESwGhDihi6sSQhiXpAc7ZM67nCYYR2YwXePsdsyAMxjesAtGS3KdYHUMeG_xJwPXswkj5OBgXMjSs-zJACPh84f3LPv2_ur28mN-_eXDp8uL69yUso1514nCFIBl26u2L1GospMtVl2DiOVQDEK2ddHLsq7KVkGrRIemE1AXXVc1yqiz7Pyoewj-x4wU9WRp_TM49DNpUcm2rXjdNAktjqgJnijgoA_BThAWLbhe49J7fYxLr3Fp3ugUVyp7-eAwdxP2f4v-5JOAt0cAU59pGkGTsZhm1duAJure2_85_CtgRuusgfE7Lkh7P4c01dSLJqm5vllXZt2YdLiqhFS_AWZTwQ4</recordid><startdate>20140801</startdate><enddate>20140801</enddate><creator>Zhang, Binglan</creator><creator>Zhu, Fuping</creator><creator>Ma, Xuelei</creator><creator>Tian, Ye</creator><creator>Cao, Dan</creator><creator>Luo, Songe</creator><creator>Xuan, Yu</creator><creator>Liu, Lei</creator><creator>Wei, Yuquan</creator><general>Elsevier Ireland Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20140801</creationdate><title>Matched-pair comparisons of stereotactic body radiotherapy (SBRT) versus surgery for the treatment of early stage non-small cell lung cancer: A systematic review and meta-analysis</title><author>Zhang, Binglan ; Zhu, Fuping ; Ma, Xuelei ; Tian, Ye ; Cao, Dan ; Luo, Songe ; Xuan, Yu ; Liu, Lei ; Wei, Yuquan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c529t-bb14c4ae59d39d5e135b29e6b8eee5f4f12974d2576593a931becb1a74bb683c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Carcinoma, Non-Small-Cell Lung - pathology</topic><topic>Carcinoma, Non-Small-Cell Lung - surgery</topic><topic>Disease-Free Survival</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Lung cancer</topic><topic>Lung Neoplasms - pathology</topic><topic>Lung Neoplasms - surgery</topic><topic>Matched-Pair Analysis</topic><topic>Meta-analysis</topic><topic>Neoplasm Staging</topic><topic>Prospective Studies</topic><topic>Radiosurgery - methods</topic><topic>Stereotactic body radiotherapy</topic><topic>Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Binglan</creatorcontrib><creatorcontrib>Zhu, Fuping</creatorcontrib><creatorcontrib>Ma, Xuelei</creatorcontrib><creatorcontrib>Tian, Ye</creatorcontrib><creatorcontrib>Cao, Dan</creatorcontrib><creatorcontrib>Luo, Songe</creatorcontrib><creatorcontrib>Xuan, Yu</creatorcontrib><creatorcontrib>Liu, Lei</creatorcontrib><creatorcontrib>Wei, Yuquan</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Radiotherapy and oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Binglan</au><au>Zhu, Fuping</au><au>Ma, Xuelei</au><au>Tian, Ye</au><au>Cao, Dan</au><au>Luo, Songe</au><au>Xuan, Yu</au><au>Liu, Lei</au><au>Wei, Yuquan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Matched-pair comparisons of stereotactic body radiotherapy (SBRT) versus surgery for the treatment of early stage non-small cell lung cancer: A systematic review and meta-analysis</atitle><jtitle>Radiotherapy and oncology</jtitle><addtitle>Radiother Oncol</addtitle><date>2014-08-01</date><risdate>2014</risdate><volume>112</volume><issue>2</issue><spage>250</spage><epage>255</epage><pages>250-255</pages><issn>0167-8140</issn><eissn>1879-0887</eissn><abstract>Abstract Purpose A population-based matched-pair comparison was performed to compare the efficacy of stereotactic body radiotherapy (SBRT) versus surgery for early-stage non-small cell lung cancer (NSCLC). Methods All the eligible studies were searched by PubMed, Medline, Embase, and the Cochrane Library. The meta-analysis was performed to compare odds ratios (OR) for overall survival (OS), cancer-specific survival (CSS), disease-free survival (DFS), local control (LC), and distant control (DC). Results Six studies containing 864 matched patients were included in the meta-analysis. The surgery was associated with a better long-term OS in patients with early-stage NSCLC. The pooled OR and 95% confidence interval (CI) for 1-year, 3-year OS were 1.31 [0.90, 1.91] and 1.82 [1.38, 2.40], respectively. However, the difference in 1-year and 3-year CSS, DFS, LC and DC was not significant. Conclusions This systematic review found a superior 3-year OS after surgery compared with SBRT, which supports the need to compare both treatments in large prospective, randomized, controlled clinical trials.</abstract><cop>Ireland</cop><pub>Elsevier Ireland Ltd</pub><pmid>25236716</pmid><doi>10.1016/j.radonc.2014.08.031</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0167-8140 |
| ispartof | Radiotherapy and oncology, 2014-08, Vol.112 (2), p.250-255 |
| issn | 0167-8140 1879-0887 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1629960788 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | Carcinoma, Non-Small-Cell Lung - pathology Carcinoma, Non-Small-Cell Lung - surgery Disease-Free Survival Hematology, Oncology and Palliative Medicine Humans Lung cancer Lung Neoplasms - pathology Lung Neoplasms - surgery Matched-Pair Analysis Meta-analysis Neoplasm Staging Prospective Studies Radiosurgery - methods Stereotactic body radiotherapy Surgery |
| title | Matched-pair comparisons of stereotactic body radiotherapy (SBRT) versus surgery for the treatment of early stage non-small cell lung cancer: A systematic review and meta-analysis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T03%3A45%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Matched-pair%20comparisons%20of%20stereotactic%20body%20radiotherapy%20(SBRT)%20versus%20surgery%20for%20the%20treatment%20of%20early%20stage%20non-small%20cell%20lung%20cancer:%20A%20systematic%20review%20and%20meta-analysis&rft.jtitle=Radiotherapy%20and%20oncology&rft.au=Zhang,%20Binglan&rft.date=2014-08-01&rft.volume=112&rft.issue=2&rft.spage=250&rft.epage=255&rft.pages=250-255&rft.issn=0167-8140&rft.eissn=1879-0887&rft_id=info:doi/10.1016/j.radonc.2014.08.031&rft_dat=%3Cproquest_cross%3E1629960788%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1629960788&rft_id=info:pmid/25236716&rft_els_id=1_s2_0_S0167814014003612&rfr_iscdi=true |